Download Restless Legs Syndrome

Survey
yes no Was this document useful for you?
   Thank you for your participation!

* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project

Document related concepts
no text concepts found
Transcript
Restless Legs Syndrome
David Atkins
2-28-08
PAS 645-646
What is RLS ?
• Restless Legs Syndrome (RLS) is a
sensorimotor movement disorder.
• Characterized by:
– an uncontrollable urge to move the legs
– symptoms typically begin in the evening or at
bedtime, preventing the sufferer from falling
asleep
Is RLS even REAL?
YES.
HISTORY of RLS
• Phenomenon was described as early as
17th century by Thomas Willis.
• Closely observed in 1945 by Karl-Axel
Ekbom who coined the term "Restless
legs" (formerly called "Ekbom-syndrome").
• Diagnostic criteria outlined by International
RLS Study Group (IRLSSG) in 1995.
Revised in 2003.
Epidemiology
Roughly 10% prevalence in the general
population of U.S. and Western Europe.
Significantly lower rates in African
Americans.
Higher incidence in women?
Etiology
• IDIOPATHIC
• Genetic Linkage: 3 separate loci have
been identified, none solely responsible.
• Most research is aimed at dopamine
and/or iron pathologies.
Two Forms of RLS:
• Primary (idiopathic):
Secondary RLS:
• Early onset: usually
manifests before 45
• Later age of onset
• Familial: >60% have at
least 1 primary family
member with RLS.
• No family history of RLS
• More gradual progression
of Sx over time.
• Rapid progression of Sx.
Secondary RLS
• Usually related to disorders that result in
iron deficiency.
• Most common underlying causes of
secondary RLS:
– Pregnancy
– Anemia
– End-stage renal disease
– ADHD
Diagnosing RLS
Treating RLS
• There is no cure, Tx is symptomatic only
• Pharmacologic vs. Non-pharmicologic
• Many treatments out there, but all lack
sufficient research…studies are ongoing.
ALWAYS try non-pharm. Tx
Behavioral/Lifestyle
modification:
Practice good sleep hygeine
Regular moderate exercise,
but at the right times
Other anecdotal methods
st
1
Avoid Sx aggravators:
caffeine
nicotine
alcohol
diphenhydramine
TCA's
SSRI's
neuroleptics
NON-Pharmacologic Tx:
IRON
• Iron supplementation: 50-65mg tid (+Vit C)
• IV: sodium ferric gluconate or iron sucrose
• Only beneficial if serum ferritin <50μg/L
Pharmocologic Tx
• DA-agonists are drugs of choice:
– Levadopa (d.o.c. for intermittent RLS)
– Ropinirole (Requip®) FDA approved for RLS in
May, 2005.
– Pramipexole (Mirapex®) FDA approved for RLS
in November, 2006.
• Both indicated for moderate-severe RLS.
• No studies (yet) comparing ropinirole to pramipexole
Other Rx options:
• Opioids
• Benzodiazepines
• Anti-convulsants
• BZDP's: very popular before DA-agonists
became first line, with good results.
• Both BZDP's and Opioids have low dependence
and abuse potential when used for RLS
Pharmacologic Tx
As a clinician...
•
•
•
•
•
•
Diagnose RLS using essential criteria.
-Consider +FH, underlying cause, and assess iron status
Educate patient and attempt nonpharmacologic therapies (d/c Sx aggravators)
If non-pharm Tx fails, Rx a dopaminergic.
If dopaminergics fail, try one of the "others".
May use combo of dopaminergic + "other".
Remember: all pts experience RLS and
respond to Tx differently.
References:
Essential Dx table:
Patrick L. Restless Legs Syndrome: Pathophysiology and the Role of
Iron and Folate. Altern Med Rev. 2007 Jun;12(2):101-12.
Common Pharmacologic drugs:
Hening WA. Current guidelines and standards of practice for restless
legs syndrome.
Am J Med. 2007 Jan;120 (1 Suppl 1):S22-7.
Tx Algorithm:
Ryan M, Slevin JT. Restless legs syndrome. Am J Health Syst Pharm.
2006 Sep;63(17):1599-612.